SCHEMBL3344603

SCHEMBL3344603

c1ccc(-c2ccc(C(c3c[nH]c4ccccc34)c3c[nH]c4ccccc34)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.61
PGR P06401 1/20 0.61
NR3C2 P08235 1/20 0.61
AR P10275 1/20 0.61
MGAM O43451 6/20 0.60
GAA P10253 6/20 0.60
SI P14410 6/20 0.60
MGAM2 Q2M2H8 6/20 0.60
MAPT P10636 4/20 0.57
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343111 0.89 MAPT (0.69) NR3C1PGRNR3C2ARMGAM
SCHEMBL30040360 0.89 MAPT (0.69) NR3C1PGRNR3C2ARMGAM
SCHEMBL10717194 0.85 NR3C1 (0.73) NR3C1PGRNR3C2ARMGAM
SCHEMBL18364667 0.83 MAPT (0.54) NR3C1PGRNR3C2ARMGAM
SCHEMBL18364660 0.83 GPR84 (0.56) NR3C1PGRNR3C2ARMGAM
SCHEMBL24145185 0.83 NR3C1 (0.57) NR3C1PGRNR3C2ARMGAM
SCHEMBL3495495 0.83 GUSB (0.61) NR3C1PGRNR3C2ARMGAM
SCHEMBL31511311 0.83 NR3C1 (0.57) NR3C1PGRNR3C2ARMGAM
SCHEMBL3493350 0.83 GUSB (0.58) NR3C1PGRNR3C2ARMGAM
SCHEMBL29540078 0.83 GUSB (0.61) NR3C1PGRNR3C2ARMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010042657-A1 USE OF DIINDOLYLMETHANE (DIM) COMPOUNDS AND DERIVATIVES AS NEUROPROTECTIVE AGENTS COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-04-15 WO claimed
US-20100087504-A1 Use of Diindolylmethane (DIM) Compounds and Derivatives as Neuroprotective Agents COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-04-08 US claimed
US-20210024499-A1 OXIDIZED BIS(3-INDOLYL)METHANES AND USES THEREOF XIAMEN UNIVERSITY (CN) 2021-01-28 US disclosed
WO-2019183527-A1 OXIDIZED BIS(3-INDOLYL)METHANES AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2019-09-26 WO disclosed
US-8580843-B2 Use of diindolylmethane (DIM) compounds and derivatives as neuroprotective agents COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-11-12 US disclosed
US-8580843-B2 Use of diindolylmethane (DIM) compounds and derivatives as neuroprotective agents COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-11-12 US disclosed
US-8580843-B2 Use of diindolylmethane (DIM) compounds and derivatives as neuroprotective agents COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-11-12 US disclosed
WO-2010042657-A1 USE OF DIINDOLYLMETHANE (DIM) COMPOUNDS AND DERIVATIVES AS NEUROPROTECTIVE AGENTS COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-04-15 WO disclosed
WO-2010042657-A1 USE OF DIINDOLYLMETHANE (DIM) COMPOUNDS AND DERIVATIVES AS NEUROPROTECTIVE AGENTS COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-04-15 WO disclosed
US-20100087504-A1 Use of Diindolylmethane (DIM) Compounds and Derivatives as Neuroprotective Agents COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-04-08 US disclosed
US-20100087504-A1 Use of Diindolylmethane (DIM) Compounds and Derivatives as Neuroprotective Agents COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-04-08 US disclosed
US-20100087504-A1 Use of Diindolylmethane (DIM) Compounds and Derivatives as Neuroprotective Agents COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087504-A1 Use of Diindolylmethane (DIM) Compounds and Derivatives as Neuroprotective Agents AIFM1, NLN, SNCA NR3C1 2043/4885PGR 3216/4885NR3C2 2843/4885
US-20210024499-A1 OXIDIZED BIS(3-INDOLYL)METHANES AND USES THEREOF BCL2, BCOR, BCLAF1 NR3C1 71/4885PGR 893/4885NR3C2 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.